Raymond James hires Gary Nachman as senior life sciences analyst

ST. PETERSBURG, Fla. – Raymond James has hired Gary Nachman as managing director and senior research analyst in the firm's Equity Research department. Based in New York, he will cover companies in the life sciences sector, specifically focusing on specialty pharmaceuticals, biopharmaceuticals and biotechnology.

"We are thrilled to welcome Gary, an esteemed and experienced professional with a proven track record of high-quality research and strong client relationships," said Brian Alexander, senior managing director of Equity Research. "His ability to cover a wide range of companies within the life sciences ecosystem enhances our capabilities and provides us with greater breadth and depth in one of the largest and most dynamic subsectors within healthcare."

Nachman joins Raymond James from BMO Capital Markets, where he also focused on biopharma companies since 2016. He previously held similar lead analyst positions at Goldman Sachs, Susquehanna Financial Group, Leerink Swann and Morgan Stanley. Before his career in equity research, Nachman spent three years in the pharmaceutical industry at Merck, where he was a manager in the Financial Evaluation Group. Nachman earned his MBA from Columbia Business School and a Bachelor of Science in accounting from Binghamton University.

The strategic hire underscores Raymond James' continuing commitment to expanding the capabilities of its Healthcare practice. Since August, the firm has onboarded over a dozen senior professionals collaborating across Investment Banking, Equity Research, Sales & Trading and Equity Capital Markets. Operating as a cohesive unit, the group serves middle-market healthcare clients in the biotechnology, medical technology, healthcare services and healthcare technology sectors.

"We are excited about the addition of Gary to our research team. His hire reflects our continued focus on deepening our healthcare industry expertise and gaining market share within the life sciences vertical," said David De Luca, senior managing director and head of Global Equities. "With the rapidly evolving healthcare landscape, we remain committed to delivering the robust insights and results that our client base expects.”

About Raymond James Financial, Inc.

Raymond James Financial, Inc. (NYSE: RJF) is a leading diversified financial services company providing private client group, capital markets, asset management, banking and other services to individuals, corporations and municipalities. The company has approximately 8,700 financial advisors. Total client assets are $1.25 trillion (as of March 31, 2023). Public since 1983, the firm is listed on the New York Stock Exchange under the symbol RJF. Additional information is available at raymondjames.com.

© 2023 Raymond James & Associates, Inc., member New York Stock Exchange/SIPC.

  • 29 S Main St Ste 210 West Hartford, CT 06107-2449

 

Raymond James financial advisors may only conduct business with residents of the states and/or jurisdictions for which they are properly registered. Therefore, a response to a request for information may be delayed. Please note that not all of the investments and services mentioned are available in every state. Investors outside of the United States are subject to securities and tax regulations within their applicable jurisdictions that are not addressed on this site. Contact our office for information and availability.

Links are being provided for information purposes only. Raymond James is not affiliated with and does not endorse, authorize or sponsor any of the listed websites or their respective sponsors. Raymond James is not responsible for the content of any website or the collection or use of information regarding any website's users and/or members.

© 2024 Raymond James & Associates, Inc., member New York Stock Exchange / SIPC    |   Legal Disclosures   |   Privacy, Security & Account Protection   |   Terms of Use